Oncology News

In this edition, tumor mutational burden linked to immunotherapy response; toripalimab regimen extends EFS in stage III NSCLC; phase 3 study designed for increasing trial diversity, and more.

Overweight and obese BMI during adulthood appeared associated with increased risk for colorectal cancer and noncolorectal gastrointestinal cancers, according to study results published in JAMA Network Open.

All women aged 40 to 74 years should be screened for breast cancer every other year, according to a draft recommendation statement from the U.S. Preventive Services Task Force.

DESTIN, Fla. — Low disease activity and remission are achievable for patients with lupus if clinicians “minimize the prednisone” and administer adequate hydroxychloroquine, noted a speaker at the 2023 Congress of Clinical Rheumatology-East.

From 2021 to 2022, the overall death rate in the United States decreased about 5% and COVID-19 death rates nearly 50%, according to research published in Morbidity and Mortality Weekly Report.

In this episode, host Shikha Jain, MD, speaks with Edward Kim, MD about what it means to be a disruptive innovator, how to lead efforts in health care system changes and more.

In this edition, immunotherapy improves survival rates of infants with leukemia; extreme poverty linked to higher risk for relapse among children with ALL; FDA approves allogeneic cell therapy and more.

Guidelines that recommend stool-based screening for colorectal cancer should emphasize strict adherence and offer screening colonoscopy as an alternative option, researchers reported in Gastroenterology.

Black women had higher mortality rates due to breast cancer compared with other racial and ethnic groups and could benefit from earlier screening, according to researchers.

In rheumatology, there is no shortage of conditions that are difficult to diagnose, with diseases like fibromyalgia and systemic lupus erythematosus sometimes taking years before being officially identified — leading to adverse outcomes.